Back to Dimensional Fund Advisors LP Dimensional Fund Advisors LP

CLDXCLDX

Showing 6 of 26 quarters

Position history for Dimensional Fund Advisors LPDimensional Fund Advisors LP's holdings in Celldex Therapeutics, Inc.

Yes. Dimensional Fund Advisors holds 1,148,479 shares of CLDX (Celldex Therapeutics), worth $37.2M, as of its Q3 2026 13F filing. It increased the position by 74,494 shares (+6.9%) from Q2 2026. Dimensional Fund Advisors has held CLDX since Q2 2025, across 6 quarterly 13F filings.

Current Value

$37.2M

Current Shares

1.1M

Total Value Change

+$34.3M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
1.1M
+6.9%
$37.2M0.0%$32.41
31
2026-Q2
Increased
1.1M
+1.4%
$40M0.0%$37.21
29
2026-Q1
Increased
1.1M
+62.6%
$33.6M0.0%$31.72
42
2025-Q4
Increased
651,716
+153.5%
$17.7M0.0%$27.16
46
2025-Q3
Increased
257,083
+78.7%
$6.7M0.0%$25.87
42
2025-Q2
New
143,886
—
$2.9M0.0%$20.35
36

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used